Modeling Ribavirin-Induced Anemia in Patients with Chronic Hepatitis C Virus
about
Liquid chromatography-mass spectrometry methods for the intracellular determination of drugs and their metabolites: a focus on antiviral drugs.Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C.Adverse effects of direct acting antiviral-based regimens in chronic hepatitis C patients: a Brazilian experience.Effect of Sofosbuvir Plus Daclatasvir in Hepatitis C Virus Genotype-4 Patients: Promising Effect on Liver Fibrosis.Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.
P2860
Modeling Ribavirin-Induced Anemia in Patients with Chronic Hepatitis C Virus
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Modeling Ribavirin-Induced Anemia in Patients with Chronic Hepatitis C Virus
@ast
Modeling Ribavirin-Induced Anemia in Patients with Chronic Hepatitis C Virus
@en
type
label
Modeling Ribavirin-Induced Anemia in Patients with Chronic Hepatitis C Virus
@ast
Modeling Ribavirin-Induced Anemia in Patients with Chronic Hepatitis C Virus
@en
prefLabel
Modeling Ribavirin-Induced Anemia in Patients with Chronic Hepatitis C Virus
@ast
Modeling Ribavirin-Induced Anemia in Patients with Chronic Hepatitis C Virus
@en
P2093
P2860
P356
P1476
Modeling Ribavirin-Induced Anemia in Patients with Chronic Hepatitis C Virus
@en
P2093
C E MacBrayne
D Z D'Argenio
L C Jimmerson
P2860
P356
10.1002/PSP4.12058
P577
2016-02-02T00:00:00Z